WASHINGTON — Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday. The justices voted 5-3 to allow the government to inspect and challenge what it
Supreme Court: Big Pharma’s Paying To Delay Generic Drugs Can Be Challenged In Courts
Drug companies had hoped the court to would immunize their agreements, which keep cheaper forms of medicine off the market.